Journal metric profile

Molecular and Clinical Oncology

Clarivate Journal Citation Reports (JCR)-based Journal Impact Factor, five-year Impact Factor, quartile, category rank, publisher, identifiers and citation profile for the 2025 metric year.

JCR-based Impact Factor 1.400 2025 metric year
5-Year Impact Factor 1.300 Longer citation window
JCR Quartile Q4 Subject-category quartile
JCR Category Rank 269/326 Recorded category rank

Molecular and Clinical Oncology JCR impact factor overview

This profile summarizes the journal metrics and publication information available in the current directory record.

Page reviewed August 6, 2026

Molecular and Clinical Oncology metric snapshot

Molecular and Clinical Oncology has a bibliometric profile in this directory for 2025. The publisher recorded for the journal is SPANDIDOS PUBL LTD. Its listed Clarivate Journal Citation Reports (JCR)-based Journal Impact Factor is 1.400. The five-year Journal Impact Factor is 1.300, giving a second citation window for comparison. The journal is recorded in quartile Q4 for its listed JCR category.

Category position and quartile

The recorded JCR category position is 269 out of 326 journals. Based on that rank position, the journal sits within approximately the top 83% of the listed category. Its listed quartile is Q4. Category ranks and quartiles are field-specific and are not measures of the quality of an individual article.

How the citation indicators compare

The five-year Journal Impact Factor (1.300) is 0.100 points lower than the standard Journal Impact Factor (1.400). The Impact Factor without journal self-citations is the same as the listed standard value at the displayed precision. The Journal Citation Indicator (JCI) is recorded as 0.280. These measures use different definitions or citation windows, so they are most useful when read together rather than treated as interchangeable scores.

Citation and publication counts

For 2025, the directory record for Molecular and Clinical Oncology lists total cites: 2,972; total articles: 74; citable items: 96. These fields describe different parts of the JCR record and should not be combined into an article-level quality score.

Citation half-life profile

The cited half-life is 6.7 years, indicating the median age of items that contributed citations to the journal in the reporting framework. The citing half-life is 6.5 years, indicating the median age of references used by the journal’s articles.

Identifiers and verification

Molecular and Clinical Oncology is identified in this directory by print ISSN 2049-9450 and electronic ISSN 2049-9469. The publisher is recorded as SPANDIDOS PUBL LTD. When making submission, library, or research-evaluation decisions, verify the title and identifiers against the journal publisher and the official Clarivate Journal Citation Reports record.

Complete journal information

Use this table to verify the individual metric values, identifiers and publication details stored for this journal.

Journal nameMolecular and Clinical Oncology
Abbreviated journalMOL CLIN ONCOL
PublisherSPANDIDOS PUBL LTD
Metric year2025
Overall rank11,211
ISSN2049-9450
eISSN2049-9469
Total cites2,972
Total articles74
Citable items96
Cited half-life6.7 years
Citing half-life6.5 years
JCR-based Journal Impact Factor1.400
5-Year Impact Factor1.300
Impact Factor without journal self-cites1.400
Journal Citation Indicator0.280
JCR Impact Factor quartileQ4
JCR category rank269/326
Database record updated

Frequently asked questions

What is the 2025 JCR-based Journal Impact Factor of Molecular and Clinical Oncology?

The Journal Impact Factor recorded in this directory as a Clarivate Journal Citation Reports (JCR)-based value for Molecular and Clinical Oncology is 1.400 for the 2025 metric year.

What are the JCR quartile and category rank of Molecular and Clinical Oncology?

Molecular and Clinical Oncology is listed with quartile Q4 and category rank 269/326. These values are category-specific and should be verified against the official JCR record when used for formal assessment.

What is the five-year Journal Impact Factor of Molecular and Clinical Oncology?

The five-year Journal Impact Factor recorded for Molecular and Clinical Oncology is 1.300. It uses a longer citation window than the standard Journal Impact Factor.

Who publishes Molecular and Clinical Oncology?

Molecular and Clinical Oncology is listed in this directory as being published by SPANDIDOS PUBL LTD.

Additional records from the same publisher or with a similar listed JCR Impact Factor.